43 results
Thumbnail

D1.58 - Pilocarpine in the management of allergic rhinosinusitis; a prospective, placebo-controlled study for a novel use of a cholinergic agent

Thumbnail

D1.68 - Rice allergy: a case report

Thumbnail

D1.59 - Asymptomatic sensitisation to food allergens is common in adults -findings from the PAFA study

Thumbnail

D1.60 - Impact of real-world confounders on the accuracy of an AI model to support the read out of skin prick automated test results

Thumbnail

D1.62 - Improved In-vitro Allergy Diagnostics using a Molecular Composite of Purified Peanut Allergens

Thumbnail

D1.63 - Descriptive Study on the Evolution of Patients Treated with Oral Immunotherapy (OIT) Using Pasteurized Egg White at the Fundación Alcorcón University Hospital

Thumbnail

D1.64 - Severe Food Protein-Induced Enterocolitis Syndrome: A French Multicenter Study of Children Admitted to Critical Care

Thumbnail

D1.65 - Pollen Food Allergy Syndrome in Patients with Quercus ilex Sensitization in the Population of Madrid

Thumbnail

D1.66 - Reactivity, severity and tolerance development in 50 wheat-allergic children across two oral food challenges

Thumbnail

D1.67 - Development and validation of Skin Prick Test solutions for assessing sensitization patterns to edible insects among children sensitized to house dust mite

Thumbnail

D1.69 - Safety in the peach juice food challenge in LTP allergic patients

Thumbnail

D1.70 - No more restrictive diets for LTP allergic patients. The importance of oral food challenge

Thumbnail

D1.71 - Risk Factors for Anaphylaxis in Food-Allergic Children During Oral Food Challenge Tests

Thumbnail

D1.72 - Comparison of the allergenic composition of available SPTs for the diagnosis of sensitization to D. pteronyssinus

Thumbnail

D1.57 - Antigen-specific IgE antibody levels as negative predictors of oral food challenge with cow's milk in children with cow's milk allergy

Thumbnail

D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma

Thumbnail

D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)

Thumbnail

D1.152 - Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units

Thumbnail

D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites

Thumbnail

D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix